Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dalpiciclib”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Large-scale testing (Phase 3)Looking for participantsNCT07207070
What this trial is testing

A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Risen (Suzhou) Pharma Tech Co., Ltd. 312
Not applicableUnknownNCT06344780
What this trial is testing

Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 200
Testing effectiveness (Phase 2)Looking for participantsNCT06107673
What this trial is testing

Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）

Who this might be right for
Breast Cancer
Hebei Medical University Fourth Hospital 144
Early research (Phase 1)Looking for participantsNCT07652762
What this trial is testing

IN10018 in Combination With Dalpiciclib for Progressive Meningiomas

Who this might be right for
MeningiomaCDK4/6 Inhibitor
Capital Medical University 24
Testing effectiveness (Phase 2)UnknownNCT05512416
What this trial is testing

Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer

Who this might be right for
Breast Cancer
The Affiliated Hospital of Qingdao University 35
Not applicableLooking for participantsNCT05578053
What this trial is testing

Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hebei Medical University Fourth Hospital 420
Testing effectiveness (Phase 2)Looking for participantsNCT05638594
What this trial is testing

Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer

Who this might be right for
Breast Cancer
Shengjing Hospital 236
Testing effectiveness (Phase 2)Looking for participantsNCT06149130
What this trial is testing

Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer

Who this might be right for
Breast Cancer
Tongji Hospital 82
Testing effectiveness (Phase 2)Looking for participantsNCT07581834
What this trial is testing

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

Who this might be right for
Breast DiseasesBreast NeoplasmsDalpiciclib+3 more
Fujian Cancer Hospital 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07810088
What this trial is testing

Dalpiciclib Combined With Aromatase Inhibitors and Olmesartan as the First-line Treatment for HR+/HER2- Advanced Breast Cancer

Who this might be right for
HR+ / HER2- Advanced Breast Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Not applicableUnknownNCT05497076
What this trial is testing

The Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generation TKI and Platinum-containing Two-drug Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer Confirmed by Histopathology or CytologyThe TNM (8th) Phase is IVWith EGFR Mutations+4 more
Fujian Cancer Hospital 9
Testing effectiveness (Phase 2)UnknownNCT05640778
What this trial is testing

Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)

Who this might be right for
Luminal B/HER2-negative Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)UnknownNCT04997798
What this trial is testing

Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor Positive TumorHER2-positive Breast Cancer
First Affiliated Hospital of Zhejiang University 30
Large-scale testing (Phase 3)Looking for participantsNCT07615751
What this trial is testing

Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 502
Testing effectiveness (Phase 2)UnknownNCT05952128
What this trial is testing

Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma

Who this might be right for
Sarcoma
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06684600
What this trial is testing

Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06556862
What this trial is testing

Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor

Who this might be right for
HR+/HER2- Advanced Breast Cancer
Beijing 302 Hospital 155
Early research (Phase 1)UnknownNCT06109207
What this trial is testing

Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 6
Large-scale testing (Phase 3)Looking for participantsNCT07354022
What this trial is testing

Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.

Who this might be right for
Locally Advanced or Metastatic Breast Cancer
Shandong Suncadia Medicine Co., Ltd. 912
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06552858
What this trial is testing

Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fudan University 30
Next Page